Ashdod, Israel, March 23, 2016 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced today that it appointed Angela Strand and Leslie Seff to its Board of Directors, effective March 23, 2016. Ms. Strand will also chair the […]
Read More Download
Sign up to our newsletter
To receive occasional news updates
GlucoTrack Model DF-F is intended for use in non-invasive quantitative spot measurement of glucose, for home-use. The GlucoTrack Model DF-F is intended for use by adults (over the age of 18 years old) type 2 diabetic patients, as well as pre-diabetic patients. Medications intake / treatment decisions should not be based only on measurements by GlucoTrack model DF-F. The GlucoTrack Model DF-F is a monitoring device and should not be used for diagnosis.
© 2017 Integrity Applications. All Rights Reserved.